Candida Proteases and Their Inhibition Prospects for Antifungal Therapy

Author(s): K. Stewart, C. Abad-Zapatero.

Journal Name: Current Medicinal Chemistry

Volume 8 , Issue 8 , 2001

Become EABM
Become Reviewer


The rationale for inhibition of the secreted acid proteases (SAP) of Candida fungal species as a novel antifungal strategy is outlined. Enzyme structure-activity relationship data regarding the inhibitor A-70450 are described along with results from in vivo antifungal assays. Developments from protein X-ray crystallographic studies, SAP knock-out genetic studies, and the importance of these new results for drug discovery are reviewed. Finally, inhibition of the Candida SAP enzymes with HIV protease inhibitors and a proposed role in candidiasis of AIDS patients is discussed.

Keywords: Candida Proteases, Antifungal Therapy, secreted acid proteases (SAP), Candida fungal species, fluconazole, echinocandin B, amphotericin, HIV PROTEASE INHIBITORS

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2001
Page: [941 - 948]
Pages: 8
DOI: 10.2174/0929867013372698
Price: $58

Article Metrics

PDF: 12